Answers are grounded in this paper and cite their sources.
Computational design of artificial metalloenzymes shows promise for neuroprotection in ischemic stroke, suggesting a new therapeutic approach.
Ischemic stroke is a life-threatening cerebrovascular condition in which reperfusion, although critical for restoring cerebral blood flow, often induces severe oxidative stress and exacerbates tissue injury. The development of effective antioxidant therapies remains a formidable challenge. Here, through computational screening of ten metal centers, we introduce the design of bioinspired artificial metalloenzymes with efficient cascade biocatalysis to alleviate cerebral ischemia-reperfusion injury. The optimized artificial metalloenzymes are constructed using iridium-cluster-doped Mn-organic complexes (Ir-MnOC), which function as artificial antioxidases with cascade biocatalytic properties to efficiently eliminate reactive oxygen species (ROS), thereby mitigating inflammation and protecting against cerebral ischemia-reperfusion injury. Combined experimental and theoretical analyses reveal strong electronic coupling within the Ir-Mn organic complex, which optimizes the orbital energy levels of the metal centers, while Mn-coordinated ligands modulate oxygen species adsorption, collectively enhancing biocatalytic kinetics. As a result, the Ir-MnOC reduces ROS-mediated neuronal apoptosis by alleviating oxidative stress and exerts anti-inflammatory effects by suppressing lipid peroxidation and inhibiting microglial and astrocytic activation. Ultimately, this multienzyme-inspired biomimetic system promotes functional recovery after cerebral ischemia reperfusion, offering a promising therapeutic strategy for ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Xing et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: